← Leaderboards
Michael M. Ittmann
Baylor College Of Medicine
$8,988,557
Attributed
$8,988,557
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,268,119 · 13
VA$0 · 1
By mechanism
P50$3,818,330 · 1
R01$2,470,289 · 3
P30$2,283,576 · 4
U01$1,911,784 · 1
U54$1,861,676 · 2
P20$922,464 · 2
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Timothy C Thompson$13,464,867
- Francesco John Demayo$23,405,197
- Carolyn L Smith$8,508,837
- Norman Michael Greenberg$14,007,258
- Daniel Kraushaar$783,213
Others in their field
Top investigators on “Human Tissue”
- David Heimbrook · Leidos Biomedical Research, Inc.$294,443,261
- Lawrence Corey · Fred Hutchinson Cancer Center$212,638,156
- Larry Arthur$131,303,476
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$114,079,276
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
Research focus
Human TissueTissuesBaseMalignant NeoplasmsMouse ModelPathologyProstateNormal Tissue MorphologyIn VivoCellsTissue MicroarrayResourcesParaffin EmbeddingImmunohistochemistryPlayMalignant Neoplasm Of ProstateEvaluationLaser Capture MicrodissectionSpecimenProteinsProgramsCytokineEpithelialAnticancer Research
Grant awards (48)
Integrated Biobanking Shared Resource$229,084
P30 · FY2025 · CA · contact PI
Integrated Biobanking Shared Resource$298,016
P30 · FY2024 · CA · contact PI
Integrated Biobanking Shared Resource$298,016
P30 · FY2023 · CA · contact PI
Integrated Biobanking Shared Resource$298,016
P30 · FY2022 · CA · contact PI
A novel oncogenic axis in African American prostate cancer$0
I01 · FY2022 · VA · contact PI
Integrated Biobanking Shared Resource$288,022
P30 · FY2021 · CA · contact PI
A novel oncogenic axis in African American prostate cancer$0
I01 · FY2021 · VA · contact PI
Integrated Biobanking Shared Resource$298,016
P30 · FY2020 · CA · contact PI
A novel oncogenic axis in African American prostate cancer$0
I01 · FY2020 · VA · contact PI
Shared Resource: Human Tissue Acquisition and Pathology$126,313
P30 · FY2019 · CA · contact PI
A novel oncogenic axis in African American prostate cancer$0
I01 · FY2019 · VA · contact PI
PDX Core$1,189,380
U54 · FY2018 · CA · contact PI
Shared Resource: Human Tissue Acquisition and Pathology$117,619
P30 · FY2018 · CA · contact PI
Shared Resource: Human Tissue Acquisition and Pathology$10,000
P30 · FY2018 · CA · contact PI
Shared Resource: Human Tissue Acquisition and Pathology$4,755
P30 · FY2018 · CA · contact PI
Highly specific targeting of the TMPRSS2/ERG fusion gene in prostate cancer$0
I01 · FY2018 · VA · contact PI
Shared Resource: Human Tissue Acquisition and Pathology$101,811
P30 · FY2017 · CA · contact PI
Highly specific targeting of the TMPRSS2/ERG fusion gene in prostate cancer$0
I01 · FY2017 · VA · contact PI
Shared Resource: Human Tissue Acquisition and Pathology$101,811
P30 · FY2016 · CA · contact PI
Highly specific targeting of the TMPRSS2/ERG fusion gene in prostate cancer$0
I01 · FY2016 · VA · contact PI
Shared Resource: Human Tissue Acquisition and Pathology$112,097
P30 · FY2015 · CA · contact PI
Highly specific targeting of the TMPRSS2/ERG fusion gene in prostate cancer$0
I01 · FY2015 · VA · contact PI
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion$541,659
U01 · FY2013 · CA · contact PI
Mechanisms of Cytokine Induced Lower Urinary Track Pathology$156,500
P20 · FY2013 · DK · contact PI
Mechanisms of Cytokine Induced Lower Urinary Track Pathology$156,500
P20 · FY2013 · DK · contact PI
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion$671,170
U01 · FY2012 · CA · contact PI
Mechanisms of Cytokine Induced Lower Urinary Track Pathology$304,732
P20 · FY2012 · DK · contact PI
Mechanisms of Cytokine Induced Lower Urinary Track Pathology$304,732
P20 · FY2012 · DK · contact PI
Cellular Senescence in the Pathogenesis of Benign Prostatic Hyperplasia$229,054
R01 · FY2012 · DK · contact PI
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion$698,955
U01 · FY2011 · CA · contact PI
Cellular Senescence in the Pathogenesis of Benign Prostatic Hyperplasia$229,054
R01 · FY2011 · DK · contact PI
Cellular Senescence in the Pathogenesis of Benign Prostatic Hyperplasia$255,301
R01 · FY2010 · DK · contact PI
Expression Analysis and Pathology CORE$113,150
U54 · FY2010 · CA · contact PI
Cellular Senescence in the Pathogenesis of Benign Prostatic Hyperplasia$257,880
R01 · FY2009 · DK · contact PI
Expression Analysis and Pathology CORE$183,887
U54 · FY2009 · CA · contact PI
Expression Analysis and Pathology CORE$127,158
U54 · FY2008 · CA · contact PI
SPORE in Prostate Cancer$1,124,001
P50 · FY2007 · CA · contact PI
Expression Analysis and Pathology CORE$168,101
U54 · FY2007 · CA · contact PI
SPORE in Prostate Cancer$2,694,329
P50 · FY2006 · CA · contact PI
Expression Analysis and Pathology CORE$80,000
U54 · FY2006 · CA · contact PI
Cytokines and FGFs in prostate cancer progression$112,875
R01 · FY2005 · AG
Cytokines and FGFs in prostate cancer progression$112,875
R01 · FY2004 · AG
ROLE OF FIBROBLAST GROWTH FACTORS IN PROSTATE GROWTH$224,250
R01 · FY2003 · DK
Cytokines and FGFs in prostate cancer progression$188,125
R01 · FY2003 · AG
ROLE OF FIBROBLAST GROWTH FACTORS IN PROSTATE GROWTH$224,250
R01 · FY2002 · DK
Cytokines and FGFs in prostate cancer progression$188,125
R01 · FY2002 · AG
ROLE OF FIBROBLAST GROWTH FACTORS IN PROSTATE GROWTH$224,250
R01 · FY2001 · DK
ROLE OF FIBROBLAST GROWTH FACTORS IN PROSTATE GROWTH$224,250
R01 · FY2000 · DK